Login / Signup

18F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter study.

Ryogo MinamimotoLuis FayadJulie VoseJane MezaRanjana AdvaniJordan HankinsFelix MottaghyHomer MacapinlacAlexander HeinzelMalik E JuweidAndrew Quon
Published in: European journal of nuclear medicine and molecular imaging (2021)
In patients with DLBCL given R-CHOP/R-EPOCH, iFLT-PET/CT is a superior independent predictor of outcome compared with iFDG-PET/CT.
Keyphrases
  • pet ct
  • diffuse large b cell lymphoma
  • free survival
  • epstein barr virus
  • positron emission tomography
  • computed tomography